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Abstract
The human gastrointestinal tract represents an environment which is a densely populated home for a microbiota
that has evolved to positively contribute to host health. At birth the essentially sterile gastrointestinal tract (GIT) is
rapidly colonized by microorganisms that originate from the mother and the surrounding environment. Within a
short timeframe a microbiota establishes within the (breastfed) infant’s GIT where bifidobacteria are among the
dominant members, although their numerical dominance disappears following weaning. The numerous health
benefits associated with bifidobacteria, and the consequent commercial relevance resulting from their
incorporation into functional foods, has led to intensified research aimed at the molecular understanding of
claimed probiotic attributes of this genus. In this review we provide the current status on the diversity and ecology
of bifidobacteria. In addition, we will discuss the molecular mechanisms that allow this intriguing group of bacteria
to colonize and persist in the GIT, so as to facilitate interaction with its host.
Introduction
Bifidobacteria are typical gut inhabitants, and represent
non-motile, non-sporulating, non-gas producing, sac-
charolytic Gram-positive bacteria that belong to the
family Bifidobacteriaceae and the phylum Actinobacteria,
the latter being one of the largest and most populated
taxonomic units in the domain Bacteria, and being com-
posed of six classes and 16 orders [1]. Actinobacteria
exhibit a wide spectrum of morphologies and metabolic
properties, and possess genomes of a high G+C content,
ranging from 46% to over 70% (for example members of
the Corynebacterium genus) [1]. Furthermore, certain
representatives of this phylum produce a range of impor-
tant secondary metabolites, including those that are
exploited as antibiotics by the pharmaceutical industry
(produced by Streptomyces spp.) [2,3].
During the last two to three decades bifidobacteria
have become the subject of intensifying scientific scru-
tiny because they represent an abundant bacterial com-
ponent of the human GIT microbiota, while they are
believed to be the most dominant bacterial group pre-
sent in the gut microbiota of vaginally delivered, breast-
fed infants [4]. They also are known to stably colonize
the GIT of various other eukaryotic hosts, including
mammals, birds and insects [5,6]. Their discovery has
been attributed to Henri Tissier who in 1899 isolated a
so-named Bacillus bifidus from breast-fed infant faeces
[7]; bifidobacteria were incorrectly assigned to the genus
Lactobacillus for much of the 20th century, and only
relatively recently obtained appropriate classification as
a separate genus, Bifidobacterium [8].
Taxonomic diversity and ecology
The Bifidobacterium genus
The Bifidobacterium genus currently comprises 48
recognized species (Table 1) [9-13]. According to taxo-
nomic classification based on comparative analyses of
16S rRNA-encoding DNA and concatenated multilocus
sequences, representing a number of conserved house-
keeping genes (clpC, dnaJ, xfp, dnaB, rpoC and purF),
bifidobacterial species have been clustered into six main
phylogenetic clusters, consisting of the Bifidobacterium
boum, Bifidobacterium asteroides, Bifidobacterium ado-
lescentis, Bifidobacterium pullorum, Bifidobacterium
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Table 1 List of currently recognized bifidobacterial species with their isolation sources.
Species Type strain Origin Sequencing status
Bifidobacterium actinocoloniiforme DSM 22766 Bumblebee digestive tract -
Bifidobacterium adolescentis ATCC 15705 Adult faeces COMPLETE
Bifidobacterium angulatum ATCC 27535 Adult faeces DRAFT
Bifidobacterium animalis subsp. animalis ATCC 25527 Sewage COMPLETE
Bifidobacterium animalis subsp. lactis DSM 10140 Fermented milk COMPLETE
Bifidobacterium asteroides ATCC 25910 Bee intestine COMPLETE
Bifidobacterium biavatii DSM 23969 Tamarind faeces -
Bifidobacterium bifidum ATCC 29521 Infant faeces COMPLETE
Bifidobacterium bohemicum DSM 22767 Bumblebee digestive tract -
Bifidobacterium bombi DSM 19703 Bumblebee digestive tract -
Bifidobacterium boum ATCC 27917 Bovine rumen -
Bifidobacterium breve ATCC 15700 Infant faeces COMPLETE
Bifidobacterium callitrichos DSM 23973 Marmoset faeces -
Bifidobacterium catenulatum ATCC 27539 Adult faeces DRAFT
Bifidobacterium choerinum ATCC 27686 Piglet faeces -
Bifidobacterium coryneforme ATCC 25911 Bee intestine -
Bifidobacterium crudilactis LMG 23609 Raw milk cheese -
Bifidobacterium cuniculi ATCC 27916 Rabbit faeces -
Bifidobacterium dentium ATCC 27534 Oral cavity COMPLETE
Bifidobacterium gallicum ATCC 49850 Human faeces DRAFT
Bifidobacterium gallinarum ATCC 33777 Chicken caecum -
Bifidobacterium indicum ATCC 25912 Bee intestine -
Bifidobacterium kashiwanohense DSM 21854 Infant faeces -
Bifidobacterium longum subsp. infantis ATCC 15697 Infant faeces COMPLETE
Bifidobacterium longum subsp. longum ATCC 15707 Adult faeces COMPLETE
Bifidobacterium longum subsp. suis ATCC 27533 Piglet faeces -
Bifidobacterium magnum ATCC 27540 Rabbit faeces -
Bifidobacterium merycicum ATCC 49391 Bovine rumen -
Bifidobacterium minimum ATCC 27538 Sewage -
Bifidobacterium mongoliense DSM 21395 Fermented milk -
Bifidobacterium moukalabense JCM 18751 Gorilla faeces -
Bifidobacterium pseudocatenulatum ATCC 27919 Infant faeces DRAFT
Bifidobacterium pseudolongum subsp. globosum ATCC 25865 Bovine rumen -
Bifidobacterium pseudolongum subsp. pseudolongum ATCC 25526 Pig faeces -
Bifidobacterium psychraerophilum LMG 21775 Porcine caecum -
Bifidobacterium pullorum ATCC 27685 Chicken faeces -
Bifidobacterium reuteri DSM 23975 Marmoset faeces -
Bifidobacterium ruminantium ATCC 49390 Bovine rumen -
Bifidobacterium saeculare ATCC 49392 Rabbit faeces -
Bifidobacterium sanguini DSM 23967 Tamarind faeces -
Bifidobacterium scardovii DSM 13734 Human sources -
Bifidobacterium stellenboschense DSM 23968 Tamarind faeces -
Bifidobacterium stercoris JCM 15918 Adult faeces -
Bifidobacterium subtile ATCC 27537 Sewage -
Bifidobacterium thermacidophilum subsp. porcinum DSM 17755 Piglet faeces -
Bifidobacterium thermacidophilum subsp. thermoacidophilum DSM 15837 Anaerobic digester -
Bifidobacterium thermophilum ATCC 25525 Piglet faeces COMPLETE
Bifidobacterium tsurumiense JCM 13495 Hamster dental plaque -
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longum, and Bifidobacterium pseudolongum phylogenetic
groups, where Bifidobacterium asteroides, isolated from
the insect gut, appears to be the closest relative of the
ancient progenitor of the genus Bifidobacterium [9].
Several of the currently recognized species have only
very recently been isolated, such as Bifidobacterium acti-
nocoloniiforme, Bifidobacterium bohemicum, Bifidobac-
terium bombi, Bifidobacterium biavatii, Bifidobacterium
reuteri, Bifidobacterium callitrichos, Bifidobacterium
sanguini, Bifidobacterium stellenboschense, Bifidobacter-
ium stercoris, Bifidobacterium kashiwanohense and Bifi-
dobacterium moukalabense [10-13]. Interestingly, as
shown in the 16S rDNA-sequence-based Neighbour-
joining tree in Figure 1, three additional phylogenetic
clusters seem to be present in Bifidobacterium, repre-
senting the B. crudilactis, B. bohemicum and B. scardovii
groups. Moreover, microbiota analysis by 16S rRNA-
encoding DNA sequences has indicated that more bifi-
dobacterial species are yet to be discovered [4,14], and
for this reason we may expect further expansion or
refinement of this classification.
Bifidobacteria have been isolated from a variety of
ecological niches, such as sewage, fermented milk and
anaerobic digestion facilities, yet are most frequently
associated with the GIT of humans and animals (in gen-
eral where the offspring of the bifidobacterial host is
raised with parental care which may ensure direct trans-
mission from mother to child/progeny) [15-17].
Their ecological adaptation may also differ among spe-
cies, some of them for instance can be present in differ-
ent niches, such as in the case of Bifidobacterium
adolescentis, Bifidobacterium animalis, Bifidobacterium
dentium and Bifidobacterium catenulatum (referred to as
cosmopolitan bifidobacterial taxa), while others appear to
be much more niche-specific, for example Bifidobacter-
ium cuniculi, Bifidobacterium angulatum and Bifidobac-
terium gallinarum (so-called specialized bifidobacterial
taxa) [18].
General genome features
Bifidobacterial chromosomes have a genome that ranges
in size between 1.9 and 2.8 Mbp, with representatives of
the B. animalis species possessing the smallest genome,
and a representative of B. longum subsp. infantis har-
bouring the largest reported genome (Table 2). Bifidobac-
terial genomes are predicted to encode a substantial
number of tRNA molecules, which averages at 52 tRNA-
encoding genes per genome, with an outlier in the case
of the B. longum subsp. infantis ATCC 15697 genome,
which contains a reported 79 tRNA-encoding genes [19]
(Table 2). Interestingly, despite the fact that bifidobac-
teria possess a tRNA-encoding gene for all common
amino acids, genes encoding the amino acyl-tRNA
synthetases for glutamine and asparagine are absent in
bifidobacteria, and the corresponding charged tRNAs are
believed to be produced with the involvement of specific
Asn- and Gln-tRNA amidotransferases, performing
transamidation of misacetylated Asp-tRNA(Asn) and
Glu-tRNA(Gln) [20,21]. The organization of the bifido-
bacterial chromosome also appears to be consistent with
that of a typical bacterial genome, showing a set of con-
served genes around the predicted origin of replication
(including rpmH, dnaA, dnaN and recF) and a region
rich in AT and multiple DnaA-binding boxes in proxi-
mity of the gene specifying the presumed chromosomal
initiator of replication (dnaA) [22]. Finally, a switch in
the direction of the GC skew [the (G-C)/(G+C) value] is
observed in bifidobacteria at the origin and terminus of
replication, so that the leading strand tends to be higher
in Guanine content as compared to its Cytosine content
[1,23]. The copy number of rRNA-specifying loci repre-
sents another variability in bifidobacterial genomes, and
ranges between two and five (Table 2).
In silico gene predictions show that representatives of
the Bifidobacterium genus contain an average of 2012
open reading frames (ORFs) per genome, where genomes
of B. animalis subsp. lactis and B. longum subsp. infantis
possess the smallest and largest number of ORFs, respec-
tively, being consistent with their genome size. It is also
possible that the lower number of genes observed in
B. animalis subsp. lactis genomes have been caused by
their wide-spread utilization in commercial preparations,
leading to phenomena of gene loss and genome decay as
a result of the adaptation to a nutrient-rich environment,
being in agreement with what was also observed in cer-
tain lactic acid bacteria [24-26].
Comparative genomics of bifidobacteria
Comparative genomic analysis of the genus Bifidobacter-
ium involving genome sequences of nine bifidobacterial
species, B. longum subsp. longum, B. longum subsp. infan-
tis, B. adolescentis, B. dentium, B. bifidum, B. animalis
subsp. lactis, B. angulatum, B. catenulatum and B. galli-
cum and full nucleotide sequence alignment revealed that
these genomes are not colinear, showing a frequent inter-
ruption of chromosomal synteny, thereby inferring the
existence of significant genome diversity within members
of the genus Bifidobacterium caused by chromosomal
rearrangment events. The Bifidobacterium core genome
was determined to consist of 506 orthologues that are
shared by all nine bifidobacterial species. Functional anno-
tation established that these core genes primarily encode
housekeeping functions, including those dedicated to
replication, transcription and translation, as well as genes
associated with adaptation to a particular niche environ-
ment, e.g. genes associated with carbohydrate metabolism,
signal transduction and cell envelope biogenesis [27]. The
number of truly unique genes (present in a single
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Figure 1 Rooted neighbour-joining tree based on the alignment (1265 nucleotides) of the 16S rRNA gene (96% of homology)
sequence from the 48 so far recognized bifidobacterial taxa (Dec., 2013). The phylogenetic groups, as highlighted in grey shaded
quadrangles, are the result of a previously performed multilocus analysis [9], integrated with the information resulting from the alignment of the
16S sequence of new bifidobacterial species.
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reference genome but absent in all other analysed gen-
omes), varies between 21 and 230 genes in the nine gen-
omes analysed. The majority of such unique genes have
no functional annotation, thereby suggesting that these
genes encode for novel biosynthetic or bifidobacterial-host
interaction molecules.
Our recent analysis of the pan-genome of the B. breve
taxon, adopting complete genome sequences of eight
B. breve strains, namely B. breve UCC2003, B. breve NCFB
2258, B. breve ATCC 20213, B. breve JCM 7017, B. breve
JCM 7019, B. breve ACS-071-V-Sch8b, B. breve 12L,
B. breve S27 established that these genomes are highly
syntenic, with the exception of B. breve ACS-071-V-Sch8b
and B. breve JCM 7017 that harbour inversions in their
genomes of 1.1 Mb and 126 Kb, respectively. Analysis of
the core and dispensable genome highlighted that the
B. breve coregenome is comprised of 1,323 core gene
families and as expected these encode functions dedicated
to cellular housekeeping. From the eight B. breve genomes
924 families of variable genes were identified and of these
426 could be classified as truly unique genes. The variable
genes encoded proteins involved in capsular polysacchar-
ide biosynthesis, phage resistance (restriction-modification
systems and CRISPR loci), production of sortase depen-
dent pili, and carbohydrate transport and utilisation.
An extension of the pangenome analysis to include gen-
omes of 6 publically available B. longum subsp. longum
sequences established that 564 gene families were uniquely
present in B. breve and absent in B. longum subsp. longum,
and while 50% of these encoded hypothetical functions the
other 50% were found to encode B. breve specific glycosyl
hydrolases, ABC transporters, CRISPR genes and mobile
elements [28].
Mobilome
The pool of mobile elements so far found in bifidobac-
teria is represented by insertion sequences, prophage-like
elements and plasmids [29,30]. Regarding insertion
sequences, representatives of the main families that have
been reported to be present in bifidobacterial genomes
are IS3, IS21, IS30, IS110, IS150, IS256, IS607/200 and
ISL3, where in general representatives of IS30 appear to
be the most abundant and active in bifidobacteria. In
fact, it has been suggested that IS30 is active in B. longum
subsp. longum and involved in causing genome deletions
and rearrangements, supporting the suggested role of IS
elements in environmental adaptation of bifidobacteria in
general [29].
In contrast to what was initially thought, bifidobacteria
appear to be subject to phage infections [30]. Sgorbati
et al [31] assessed fourteen strains of B. longum by UV
and mitomycin C induction for the release of prophage.
Bacteriophage were identified from four of the B. longum
cultures, with the phage head diameters ranging from
49-56 nm while their tails ranged in length from
76-268nm. In fact, the presence of one or more prophage-
like elements has been observed in several bifidobacterial
genomes (Table 2) [32]. The notion that prophage-like ele-
ments may act as a transmission vehicle of genes that do
not appear to be essential for phage functions (e.g.,
hypothetical proteins and glycosyl hydrolase enzymes) is
evidence for their potential involvement in lateral gene
transfer, and the acquisition of such elements may result
in an enhancement of ecological fitness in the receiving
members populating the same ecologica niche [33]. Inter-
estingly, bifidobacterial prophage insertion has in several
cases been shown to occur at a 35-bp sequence located at
the end of the gene specifying tRNAMet [30]. Moreover, an
evolutionary analysis conducted on suspected bifidobacter-
ial prophage sequences revealed in a number of cases a
high level of sequence identity with prophages present in
high and low G+C content Gram-positive bacteria, sup-
porting the hypothesis of phage-mediated DNA exchange
between Actinobacteria and Firmicutes, perhaps facilitated
by the fact that these bacteria in certain cases share a com-
mon niche [32].
The majority of bifidobacterial strains do not harbour
any plasmid and, if they do, a given isolate rarely con-
tains more than one such extrachromosomal genetic
element, which then range in size from 1.5-15 Kb. So
far, B. longum subsp. longum and B. breve represent the
species with the highest number of strains in which
plasmids have been identified, with 18 reported plasmid-
harbouring representatives of B. longum subsp. longum
and three of B. breve [29]. Analysis of their replication
(Rep) proteins has indicated that the majority of identi-
fied bifidobacterial plasmids replicate by means of the
so-called rolling circle mechanism (RCR), while other
functions, if encoded, still remain to a large degree
unknown [29].
CRISPR loci and restriction modification systems
As mentioned above, bifidobacteria were until relatively
recently not thought to be prone to phage infections since
their was no evidence of infection, however, genome ana-
lysis of several bifidobacterial strains revealed the presence
of predicted phage resistance systems, in particular
CRISPR and restriction modification (R-M) systems. The
former anti-phage system was not only found in B. ani-
malis subsp. lactis, but also in one or more representatives
of B. animalis subsp. animalis, B. longum subsp. longum,
B. breve, B. bifidum, B. dentium, B. adolescentis, B. aster-
oides, B. angulatum and B. catenulatum species [21,29].
Restriction/modification (R-M) systems are ubiquitous
among prokaryotes and generally comprise of a restric-
tion endonuclease (REase) and cognate methyltransfer-
ase (MTase) [34]. R-M systems serve primarily as
defensive instruments that protect prokaryotic cells
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against invading DNA such as promiscuous plasmids or
infecting bacteriophage as the unmodified incoming
DNA is targeted by the REase component of the R-M.
The host DNA is resistant to cleavage as the recognition
sites of the endonuclease are modified by the cognate
methyltransferase at adenosyl or cytosyl residues. R-M
systems are classified into four groups (designated type
I, II, III and IV) on the basis of their subunit composi-
tion, co-factor requirement, recognition sequence struc-
ture and the cleavage site relative to the recognition
sequence [35]. REase activity in Bifidobacterium was first
described by Khosaka et al. [36,37], who identified the
restriction endonucleases BbeI from B. breve YIT4006,
and BinSI and BinSII from B. longum subsp. infantis
S76e. Subsequently, REase activity was demonstrated in
strains of B. adolescentis, B. bifidum, B. lactentis (subse-
quently reclassified as B. longum subsp. infantis) and
B. longum subsp. longum [38-40]. In silico analysis of
sequenced bifidobacterial genomes shows that the num-
ber of R-M systems varies not only between bifidobacter-
ial species, but also between strains of a particular
species (Table 2). The genome of B. thermophilum lacks
R-M systems, while strains of B. bifidum harbour the
genetic determinants to encode between four and seven
R-M systems and genes encoding up to eight R-M sys-
tems have been identified on the sequenced genomes of
strains of B. longum subsp. infantis. The ability to cir-
cumvent the R-M complement of strains of B. longum
and B. adolescentis has allowed with the introduction of
E. coli-bifidobacterial shuttle vectors into these strains by
electroporation [41,42], while for B. breve strains it has
allowed the creation of insertion mutants via site specific
homologous recombination or transposon mutagenesis
[43], thereby advancing our understanding of bifidobac-
terial genomics, physiology and metabolism [28,44,45].
Evidence of horizontal gene transfer
Bacterial genome evolution occurs through various
mechanisms, which include gene duplication, chromoso-
mal rearrangements, vertical DNA exchange and intra-
species horizontal gene transfer (HGT), events that may
facilitate rapid environmental adaptation [46]. For this rea-
son, defining the precise evolutionary distance between
bacterial taxa is a complex and difficult task, and the pre-
sence of a common ancestor may not be sufficient in mea-
suring the true distance between two phylogenetic groups,
when also taking the presence of common functions for
genetic adaptation to a common niche into account.
HGT appears to play an important role in increasing
the competitiveness of bacteria in their ecological niche,
and in bifidobacteria DNA regions acquired through
HGT are frequently present in clusters that are ran-
domly dispersed across the genome and in many cases
being flanked by mobile elements [21,47,48].
Intestinal function
Adaptation to the gastrointestinal environment
In order to survive gastrointestinal transit and transiently
colonise the GIT, bifidobacteria must be able to counter
the adverse conditions of the oral cavity, stomach and
small intestine. In particular, exposure to oxygen or other
oxygen-derived free radicals, organic acids, and bile, as
well as osmotic stress can have a negative impact on bifi-
dobacterial cell viability and consequently probiotic func-
tionality. Bifidobacteria cope with these stressful
conditions by adopting a repertoire of molecular chaper-
ones, bile efflux transporters, bile salt hydrolases, two-
component systems and ATPases [49-55]. Tight control
of these stress-induced coping mechanisms allows bifido-
bacteria to rapidly react to various and sometimes com-
plex environmental challenges. This regulation is
governed by an interactive nextwork of regulators that
include ClgR, HspR, HrcA, and LexA. The regulons are
highly conserved among sequenced bifidobacterial gen-
omes suggesting that a universal system for adaptation to
osmotic, oxidative and acid stress exists among all mem-
bers of the Bifidobacterium genus [55]. Bile tolerance is
among the most crucial properties for a probiotic bacter-
ium as it determines a strain’s ability to survive transit
through the small intestine. The active extrusion of bile
acids and salts that accumulate in the cytoplasm through
efflux pumps is a commom mechanism employed by bac-
teria to counter bile toxicity. Multidrug transporters
belonging to the ATP-binding cassette or major facilita-
tor family have been described as mediating bile toler-
ance in strains of B. longum subsp. longum and B. breve
UCC2003 [49,56,57]. In B. breve UCC2003 Bbr_0838
encoding a multidrug transporter of the major facilitator
family is strongly induced during exposure to bile. Inacti-
vation of Bbr_0838 through insertional mutagenesis ren-
dered the mutant strain, UCC2003-838, more sensitive to
cholic acid compared to the parent strain demonstrating
that cholate is the main bile component detoxified by
Bbr_0838 [49]. Survival in the highly complex and com-
petitive environment of the GIT requires that commensal
bacteria including bifidobacteria can protect themselves
against host proteases. Some bifidobacterial species
achieve protection against human proteases, such as a-
antitrypsin and human neutrophil elastase, by a serine
protease inhibitor (Serpin), the production of which is
regulated by an environmental sensing two component
regulatory system [51,53].
Interaction with the host environment
The mechanisms by which bifidobacteria interact within
the gut environment and adhere to the host surfaces are
still under investigation and the recent availability of
several bifidobacterial genome sequences underlined the
presence of a number of macromolecules associated
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with the cellular envelope and involved in host-microbe
interactions [48,58,59]. The capsular or surface exopoly-
saccharide (sEPS) is one such macromolecule which was
shown to contribute to host colonization and persis-
tence by facilitating bifidobacterial long-term coloniza-
tion of host cells [1,60,61]. Another extracellular
structure which is crucial in the process of colonization
of the intestinal mucosa is represented by appendices
called fimbriae or pili, found in both enteric and oral
bifidobacteria [21,62-64]. They can be involved in the
establishment of host cell contact and adhesion to the
epithelial cells, in cellular aggregation or in biofilm for-
mation, but they may also stimulate a response by the
host immune system [48,59]. Bifidobacteria have long
been recognized for their ability to prevent pathogen
infection, however, the precise mechanism has remained
elusive. Recent research has demonstrated that gut
pathogen protection conferred by bifidobacteria is asso-
ciated with LuxS and AI-2 production via a mechanism
that may be correlated with iron acquisition (Christiaen
et al., submitted).
Exopolysaccharide production
A bacterial sEPS usually consists of a complex extracel-
lular structure composed of a repetition of mono/oligo-
saccharides linked through glycosidic bonds, which
determines the properties of the homo/heteropolymeric
structure. The bacterial sEPS was first studied and char-
acterized in pathogens, where such macromolecules play
a crucial role as a virulence factor in the interaction of
the bacterium with its host through modulation of the
immune system [65].
Differently from pathogens, the sEPS in commensal
bacteria (such as bifidobacteria) has only recently
received scientific attention and very little is known
about its precise biological role. The involvement of
sEPS in providing tolerance to bile salts and low pH has
previously been eluded to [66], while a recent study con-
ducted in B. breve UCC2003 demonstrated that its sur-
face-located EPS promotes in vivo persistence by
mediating evasion of the B cell-mediated adaptive
immune response in the murine gut and preventing the
production of proinflammatory cytokines such as IFN-g,
TNF-a and IL-12 [67].
The genome of B. breve UCC2003 contains two pre-
dicted EPS-encoding gene clusters: eps1, elements of
which are similar to a cluster involved in the formation
of a cell wall-associated phospho-polysaccharide or pelli-
cle in L. lactis subsp. cremoris MG1363 [68] and eps2,
which is responsible for sEPS production.
Interestingly, the eps2 locus is organized in two adja-
cent and oppositely oriented operons (called eps2A and
eps2B, Figure 2), one of which is constitutively tran-
scribed, while the other is transcriptionally silent unless
a promoter reorientation reverses this situation using a
mechanism that is likely to be similar to that observed
in Bacteroides fragilis [67,69]. More specifically, this pro-
moter inversion is presumed to be catalyzed by the pre-
sence of an inverted repeat sequence in the intergenic
region between eps2A and eps2B, and the activity of an
as yet unidentified site-specific DNA invertase/recombi-
nase [67]. Recent comparitive analysis on eight fully
sequenced B. breve genomes revealed the presence of an
intact eps2 locus in B. breve JCM 7017, B. breve JCM
7019, B. breve 689b and B. breve S27, while the genomes
of B. breve ACS-071-V-Sch8b, B. breve NCFB 2258 and
B. breve 12L appear to contain only a remnant EPS clus-
ter, where the gene encoding the priming glycosyl trans-
ferase is present, yet lacking several genes commonly
associated with EPS biosynthesis [28]. Aside from
B. breve, putative EPS-specifying regions are also present
in the genomes of most other bifidobacterial species, for
example a complete locus has been identified in mem-
bers of B. animalis subsp. lactis, B. longum subsp.
longum and B. pseudocatenulatum [61,68,70] (Table 2).
Interestingly, the G+C content of these regions deviates
from that of the genome and suggests their acquisition
through a HGT mechanism [48]. Further functional
analyses are needed to determine the structural diversity
of bifidobacterial EPS polymers and their associated bio-
logical function.
Pili in bifidobacteria
The mechanism of interaction between gut microbes
and the intestinal mucosa may involve hair-like appen-
dices, named pili or fimbriae, which are exposed on and
attached to the cellular surface. Apart from the process
of host colonization, pili may also be involved in other
cellular functions, which include protein secretion and
conjugation [71].
During colonization bifidobacteria are believed to
establish an initial contact with the host surface, fol-
lowed by a more tight and specific adhesion [48]. Two
different types of pili are held responsible for this pro-
cess: the type IVb or so-called tight adherence pili (Tad
pili) and the sortase-dependent pili. Both of these extra-
cellular structures are composed of assembled pilin sub-
units where in the case of Tad pili they are linked by
non-covalent interactions and attached to the membrane
lipid bilayer, while in the case of sortase-dependent pili
they are covalently anchored to the cell wall and their
subunit assembly involves the establishment of covalent
bonds catalyzed by a dedicated transpeptidase enzyme
(so-called sortase) [72].
Tad pili were first characterized in the Gram-negative
coccobacillus Actinobacillus actinomycetemcomitans,
where they are shown to be required for adhesion to
host surfaces, colonization and pathogenesis [73,74].
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The assembly apparatus is composed of an ATPase
(TadA) associated with two membrane proteins (TadB
and TadC), together constituting the secretion system, a
septum site-determining protein (TadZ), which directs
the pilus secretion machinery to a cell-polar position,
and finally a peptidase (TadV), which cleaves a leader
peptide from the prepilin precursors [75]. This locus is
present in both Bacteria and Archea, and is for this rea-
son termed a Widespread Colonization Island (WCI)
because of its common presence among and apparent
mobility between phylogenetically distant micro-organ-
isms [76]. Highly homologous Tad pili-encoding genes
are present in all currently sequenced bifidobacterial
genomes, which enforces their presumed role in the
establishment of a direct interaction with their host. A
recent description of the genome sequence of B. breve
UCC2003, together with an in vivo transcriptomic and
mutational analysis, confirmed the involvement of Tad
pili in murine gut colonization by B. breve [48].
In contrast, sortase-dependent pili have been observed
decorating the bifidobacterial cell surface and their expres-
sion seems to be strongly dependent on growth conditions
[64]. One or more sortase-dependent pilus-encoding loci
are present in the genome of most, but not all, bifidobac-
terial species (Table 2), where B. dentium represents the
bifidobacterial species with the highest number of pilus-
encoding loci (Table 2) [21]. A typical sortase-dependent
pilus-specifying locus in a bifidobacterial genome consists
of a gene cluster composed of one or two pilus subunit-
encoding genes with a dedicated sortase-encoding gene
placed in an adjacent position [64].
Various sortase-dependent pilus-specifying clusters
found in other bacteria are thought to have been
acquired through lateral transfer due to their deviating
(G+C) content, and a phylogenetic analysis conducted
on bifidobacterial gene clusters predicted to be involved
in the biosynthesis of sortase-dependent pilus-like struc-
tures was shown to be consistent with this notion [71].
Notably, a recent study conducted on B. bifidum
PRL2010 established an additional function of sortase-
dependent pili as they were not only shown to be involved
in the specific binding to extracellular matrix components
(in this case fibronectin and collagen), but were also
shown to be responsible for bacterial aggregation [59].
Figure 2 Genome atlas of B. breve UCC2003. Surrounding the genome are schematic representations of selected genes or gene clusters that
have been characterised through comparative and functional genomic approaches using B. breve UCC2003 as a model Bifidobacterium strain.
The proven function of each gene/gene cluster is indicated together with the gene name and gene ID, see text for further explanations and
relevant references.
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Perhaps this aggregation phenotype may allow individual
cells of this gut commensal to adhere to each other in
order to enhance the colonization of the host mucosa,
using a mechanism similar to the one described for the
probiotic strain Lactobacillus rhamnosus GG [77,78].
Moreover, this study demonstrated that such pili play a
role in modulating the host immune response, on the one
hand inducing a high level of expression of TNF-a cyto-
kines known to be produced at local level as a result of
inflammatory disease, while on the other hand acting as
low-level inducers of other proinflammatory cytokines (e.
g., IL-12), associated with systemic responses [59].
Furthermore, the induction of TNF-a exerted by pili of
PRL2010 cells may be crucial for the initiation of cross-
talk among immune cells without causing any inflamma-
tion or detrimental effects [79]. In fact, the infant’s
immune system is immature and the presence of pro-
inflammatory stimuli such as those provoked by pili of B.
bifidum PRL2010 may be essential to achieve appropriate
developmental immunological programming [59].
AI-2 production by bifidobacteria
A wide range of Gram-negative and Gram-positive bac-
terial species produce the quorum sensing molecule
AI-2 and for this reason it is often referred to as the
interspecies signaling molecule. The key enzyme for
AI-2 production is LuxS, which is an essential part of
the activated methyl cycle, involved in recycling S-ade-
nosylhomocysteine. More specifically, LuxS catalyzes the
cleavage of S-ribosyl-homocysteine to homocysteine and
4,5-dihydroxy-2,3-pentanedione (DPD), which subse-
quently leads to the production of AI-2 [80]. Although
AI-2 is commonly linked to virulence and pathogenicity
[81,82], it has recently been shown that probiotic Lacto-
bacillus strains, including Lactobacillus acidophilus
NCFM, Lactobacillus rhamnosus GG and Lactobacillus
reuteri, each harbour a functional luxS gene and pro-
duce AI-2 [83-86]. We recently established that all Bifi-
dobacterium strains sequenced to date harbor a luxS
gene, and our investigations have demonstrated that all
tested bifidobacterial strains, representing 11 species of
this genus, were capable of producing AI-2. Through
insertional inactivation and subsequent complementa-
tion experiments we demonstrated that a functional
luxS gene is necessary for bifidobacterial AI-2 produc-
tion. In addition, we observed downregulation of genes
associated with iron transport in a luxS insertion mutant
strain, UCC2003-luxS, during in vitro growth. Consis-
tent with this result UCC2003-luxS was shown to be
more sensitive to various iron chelators, and unable to
colonize the murine gastrointestinal tract, while this
mutant also conferred less protection against Salmonella
infection in a C. elegans nematode model. Collectively
these data demonstrate the importance of LuxS for
bifidobacteria to establish as gut commensals, which
also includes their beneficial effect pertaining to patho-
gen protection/exclusion [87]. Furthermore, our results
indicate that LuxS activity is involved in iron acquisi-
tion, a property that gives B. breve UCC2003 a competi-
tive advantage in iron-limited environments such as the
gastrointestinal tract.
Production of bioactive metabolites
Metabolic end products, such as SCFA, vitamins, polyun-
saturated fatty acids such as conjugated linoleic acid also
contribute to intestinal functionality and probiotic attri-
butes of bifidobacteria. SCFAs are the end products of
bifidobacterial fermentation of complex carbohydrates in
the GIT, and have been found to be key for human
metabolism as they stimulate water and sodium absorp-
tion, lower luminal pH and the bioavailability of toxic
amines [88]. Recently, it was shown that acetate produced
by bifidobacteria could enhance intestinal defence
mediated by epithelial cells and thereby protecting the
host against infection by E. coli O157:H7 [89]. In addi-
tion, while bifidobacteria do not produce butyrate as an
end product of fermentation, de Vuyst and Leroy have
demonstrated the importance of cross-feeding on acetate
by butyrate-producing bacteria in the gut [90]. Butyrate is
the primary energy source for colonocytes and has
attracted much research interest due to the possibility of
its use for the prevention of colon cancer [91]. Conju-
gated linoleic acid (CLA) refers to a mixture of positional
and geometric isomers of the essential fatty acid linoleic
acid (C18:2, cis-9, cis-12 octadecadienoic acid). CLA has
been reported to be produced by some human bacterial
isolates from different bacterial groups that include
Lactobacillus, Propionibacterium, Bifidobacterium, Pedio-
coccus, Enterococcus and Lactococcus. Among bifidobac-
teria, strains of B. breve have been show to produce high
levels of CLA [92]. CLA has been shown to exert several
health benefits and has been demonstrated to have potent
anti-inflammatory, immunomodulatory, anti-obese and
anti-carcinogenic activity, along with the ability to
improve biomarkers of cardio-vascular health [93].
Carbohydrate transport and metabolism by bifidobacteria
One way by which gut commensals exert their beneficial
effect on their hosts is by degrading diet-derived carbo-
hydrates that cannot be digested by host enzymes, such
as plant-derived glycans (e.g., glucans, fructans, xylans,
resistant starch, pectins, cellulose, arabinoxylan, and
their respective oligosaccharide degradation products),
and host glycans (e.g., Human Milk Oligosaccharides or
HMO, and mucin-type O-and N-glycans).
Of such carbohydrates, bifidobacteria can degrade cer-
tain polysaccharides by extracellular enzymes into mono-
and/or oligosaccharides, which are then internalized using
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mostly sugar-specific ATP-binding cassette (ABC) trans-
porters, permeases, proton symporters and, in a few cases,
phosphoenolpyruvate-phosphotransferase (PEP-PTS)
systems [21,94]. Once internalized in the cytoplasm,
carbohydrates may be subjected to further hydrolysis, epi-
merization, deacetylation, deamination and/or phosphory-
lation involving the participation of specific enzymes, such
as glycosyl hydrolases, sugar phosphorylases, epimerases,
mutases and/or kinases [94].
All necessary genes involved in the utilization of a
given sugar are frequently organized in gene clusters
containing genes that encode one or more specific gly-
cosyl hydrolases and transport systems, and are usually
placed under the transcriptional control of a LacI-type
regulator specified by a gene that is also located adjacent
to or within such a gene cluster [62].
The fermentation pathway of simple and complex car-
bohydrates employed by bifidobacteria converges to a
specific metabolic route called “bifid shunt” which yields
2.5 ATP molecules per 1 Mol of glucose, 1.5 Mol of acet-
ate and 1 Mol of lactate. The central enzyme of this path-
way is represented by the fructose-6-phosphoketolase, of
which the encoding gene is widely used as genetic marker
for the genus Bifidobacterium [95].
In general, glucose and fructose can enter directly into
the “bifid shunt” pathway, while other sugars are
degraded by the intervention of additional glycosyl
hydrolases, depending on the strategy of niche adapta-
tion and carbon source availability [93,96-102].
According to the Cazy database classification (http://
afmb.cnrs-mrs.fr/CAZY/index. html) the glycosyl hydro-
lases that are most commonly found in bifidobacteria
belong to the GH13 (a-glucosidase and sucrose phosphory-
lase), GH36 (a-galactosidase) and GH2/42 (b-galactosi-
dase). Representatives of the GH13 family are typically
enzymes responsible for the degradation of substrates with
a-glucopyranose units, such as pullulan, glycogen, malto-
dextrin, starch, and amylopectin, and their presence has
been pointed out as a characteristic feature of B. breve
[103]. Members of the GH36 family frequently represent
enzymes dedicated to the hydrolysis of a-galacto-oligosac-
charides present in soymilk and various plants (i.e., meli-
biose, raffinose, stachyose) [102,104].
Enzymes which fall into the b-galactosidase group gener-
ate galactose that enters the central carbon metabolism
through the Leloir pathway, which is necessary for bacterial
growth on (ga)lactose-containing host-derived substrates
such as human milk oligosaccharides (HMO) and mucin.
Carbohydrate degradation capabilities of Bifidobacterium
species influence their presence and contribution to
microbiota composition
The dominance of bifidobacteria in the (breast-fed)
infant gut microbiota has been attributed to the ability
of certain bifidobacterial species to consume human
milk oligosaccharides (HMOs). Recent fecal microbiota
compositional analysis from 11 neonates established that
Actinobacteria represented the dominant phyla at 88.5%
with the Firmicutes represented at 11.1% [105]. The
most abundant classes in the infant fecal samples was
Bifidobacteriales, being present at 80.6%, while Lactoba-
cillales and Clostridiales represented the second and
third most abundant classes and being present at 7.2%
and 3.1%, respectively. The dominant Bifidobacterium
species detected in the infant fecal samples were
B. longum and B. bifidum at 56.2% and 10.7%, respec-
tively [105], while it was noted that these two Bifidobac-
terium species were apparently absent in a study that
analysed the Bifidobacterium composition of the adult
gut microbiota [106]. The dominance of B. longum and
B. bifidum in the infant gut microbiota is consistent with
their ability to use host-derived oligosaccharides such as
mucin and HMO. Mucin-type O-glycans are constituents
of mucins, which are located in different mucosal sites of
the body. The four main core glycan structures are made
up of a combination of galactose, N-acetylglucosamine,
N-acetylgalactosamine, fucose and sialic acid, linked
through various glycosidic bonds [107]. HMOs are
synthesized in the mammary gland and contain glucose,
galactose, N-acetylglucosamine, fucose and sialic acid
linked by at least 12 different glycosidic bonds [108]. The
core of both mucin-type O-glycans and HMOs is com-
posed of the same building blocks, which can be con-
nected together by various glycosidic links in order to
assume a range of structures, whose degradation still
involves a similar set of enzymes, among others b-hexo-
saminidases, b-galactosidases and a-sialidases [95,109]. A
case of differential host glycan utilization in bifidobac-
teria is represented by B. bifidum PRL2010 and
B. longum subsp. infantis ATCC 15697, of which the for-
mer is able to utilize both mucin-type glycans and HMOs
[109], while the latter is only capable of degrading HMO,
suggesting that a (partially) divergent strategy of adapta-
tion to the infant gut was applied in either of these bac-
teria [109]. While not all bifidobacterial species can
utilize HMO directly, many can cross-feed on HMO
degradation products that are liberated by the action of
extracellular glycosyl-hydrolases. These degradation pro-
ducts/cross-feeding substrates may include sialic acid,
fucose, lacto-N-tetraose (LnT) and lacto-N-biose and
their consumption by other bifidobacterial species is
likely to shape the particular composition of the infant
microbiota. This nutrient-based crossfeeding or co-
operative resource-sharing allows other bifidobacterial
species that do not directly utilize HMO to establish
themselves in the infant GIT, and supports the notion
that the diet has a definitive impact on the gut microbiota
composition.
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Previous genomic analyses have described how infant
associated bifidobacterial species (e.g. B. bifidum and
B. longum subsp. infantis) are genetically adapted to uti-
lize host produced glycans such as mucins and HMO
[110], while other bifidobacterial species including
B. breve. B. longum subsp. longum and B. adolescentis
are adapted to crossfeed on host derived glycans, while
they also harbor a repertoire of enzymes dedicated to
the metabolism of dietary plant-derived oligo- and poly-
saccharides. This diversity in carbohydrate utilization
allows persistence of particular Bifidobacterium species
in the microbiota irrespective of host age and host diet.
This notion is exemplified by B. breve UCC2003 which,
despite being a nursling stool isolate, has the capability
to utilize several plant derived carbohydrates including
starch, galactan and cellodextrins that would comprise
part of the adult diet (Figure 2). In addition, B. breve
strains can efficiently utilize LnT and sialic acid as
energy sources and can crossfeed on HMO degradation
products allowing this bifidobacterial species to establish
as part of the breast fed infant microbiota despite not
being capable of directly utilizing HMO (our unpub-
lished results).
Conclusion
It is just over 10 years since the first Bifidobacterium gen-
ome sequence was published. Since then there has been
an exponential increase in genome sequencing efforts
with, in many instances, the goal of identifying the genes,
and unravelling molecular mechanisms, associated with a
specific probiotic attribute of a particular Bifidobacterium
strain. Through comparative and functional genomics
these efforts have unveiled the mode of action for particu-
lar probiotic attributes. The next decades of bifidobacterial
research hold great promise and anticipation as additional
novel representatives of the Bifidobacterium genus are
expected to be isolated, while further insights into this
intriguing group of bacteria, and the underlying mechan-
isms that explain how they interact with their human host
and impart their probiotic effects will be unveiled.
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